Soluble ectodomain of c-erbB-2 oncoprotein in relation to tumour stage and grade in human renal cell carcinoma

about

Soluble ectodomain of c-erbB-2 oncoprotein in relation to tumour stage and grade in human renal cell carcinoma

Item

http://www.wikidata.org/entity/Q36421735

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年学术文章

@wuu

1997年学术文章

@zh-cn

1997年学术文章

@zh-hans

1997年学术文章

@zh-my

1997年学术文章

@zh-sg

1997年學術文章

@yue

1997年學術文章

@zh

1997年學術文章

@zh-hant

name

Soluble ectodomain of c-erbB-2 ...... in human renal cell carcinoma

@ast

Soluble ectodomain of c-erbB-2 ...... in human renal cell carcinoma

@en

type

Item

label

Soluble ectodomain of c-erbB-2 ...... in human renal cell carcinoma

@ast

Soluble ectodomain of c-erbB-2 ...... in human renal cell carcinoma

@en

prefLabel

Soluble ectodomain of c-erbB-2 ...... in human renal cell carcinoma

@ast

Soluble ectodomain of c-erbB-2 ...... in human renal cell carcinoma

@en

P1476

Soluble ectodomain of c-erbB-2 ...... in human renal cell carcinoma

@en

P2093

Rasmuson T

http://www.w3.org/2001/XMLSchema#string

P2860

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

Soluble c-erbB-2 fragment in serum correlates with disease stage and predicts for shortened survival in patients with early-stage and advanced breast cancer

Interaction between erbB-receptors and heregulin in breast cancer tumor progression and drug resistance.

Prognostic factors in renal cancer.

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer.

The extracellular domain of p185/neu is released from the surface of human breast carcinoma cells, SK-BR-3.

HER-2/neu oncogene protein and prognosis in breast cancer.

C-erb B-2 amplification in cystic renal disease.

P2888

bjc.1997.284

P304

1674-1677

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1997.284

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kjell Grankvist

Börje Ljungberg

P577

1997-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14035057

http://www.w3.org/2001/XMLSchema#string

P6179

1031457594

http://www.w3.org/2001/XMLSchema#string

P698

9184185

http://www.w3.org/2001/XMLSchema#string

P932

2223523

http://www.w3.org/2001/XMLSchema#string